Current Issue

Evolution of Continuous Process in Upstream and its Competition with Fed Batch Platform

Ankur Bhatnagar, Chief Scientific Manager, Cell Culture Lab* Dinesh Baskar, Senior Scien...

Sterile Products Manufacturing- prepared for the future?

Gert Moelgaard, Senior Consultant Moelgaard Consulting, www.moelgaardconsulting.com

Process Analytical Technology for Upstream Bioprocessing

Erica J. Fratz-Berilla, Staff Fellow FDA/CDER/OPQ/OBP/DBRRII Cyrus D. Agarabi, Regulator...


Featured Articles

Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection

New Paradigm of Building Quality during Manufacture – Challenges with Biological Products

Rajesh K. Gupta, Ph.D., Principal Consultant
Biologics Quality & Regulatory Consultants, LLC, North Potomac, MD 20878, USA

Development and Implementation of Process Analytical Technology (PAT) Systems in the Biopharmaceutical Sector – Challenges and Returns

Sameer Talwar1, Benoit Igne2, Juan Aon3, Dave Stevenson3, Janice Fernandez3, Diana Ritz3, Tom Eyster3, Pramthesh Patel3

1. Manufacturing Simulation and Modeling Group, GlaxoSmithKline, King of Prussia, Pennsylvania, U.S.A. 19406
2. Process Analytical Technology (PAT) Group, GlaxoSmithKline, King of Prussia, Pennsylvania, U.S.A. 19406
3. Microbial Cell Culture Development (MCCD), GlaxoSmithKline, King of Prussia, Pennsylvania, U.S.A. 19406

The future of biomanufacturing

Barbara Paldus, Ph.D.
Vice President & General Manager Finesse, part of Thermo Fisher Scientific

View All Featured Articles


© 2017 biopharma-asia.com. All rights reserved. Privacy Policy